PharmOncology

Ming-Hei Tai

5.0 (2)
MEDICINE
UPDATED WEEKLY

A podcast about pharmacy and oncology

3D AGO

Interpreting prospective ctDNA trials

Some thoughts on how to interpret ctDNA trials that look to validate it as a predictive biomarker

15 min
MAY 6

Why we should look at continuing CD38 antibodies after progression

There is an explosion of trials in the CD38 antibody space (daratumumab, isatuximab) in multiple myeloma. This episode goes over one key unanswered question which many of the trials are not attempting to answer.

10 min

2 Episodes

5

out of 5

2 Ratings

A podcast about pharmacy and oncology

Creator

Ming-Hei Tai
Years Active

2K
Episodes

2
Rating

Clean
Copyright

© Ming-Hei Tai
Show Website

PharmOncology